NCT00679601View on ClinicalTrials.gov

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Onychomycosis
Interventions
DRUG

AN2690

AN2690 7.5% Solution, once daily for 28 days

Trial Locations (1)

77802

J&S Studies, Bryan

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00679601 - Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II) | Biotech Hunter | Biotech Hunter